Early adopters of Intelligent Radiation Therapy (iRT) to date have reduced simulation to treatment planning time from seven days to seven minutes via integration with RayStation^® by RaySearch Laboratories.

Voluson Performance 18 and 16 deliver AI automation, 3D imaging, and intuitive workflows, cutting keystrokes by 65% and exams 75% faster.

The GE HealthCare PETtrace 890 cyclotron will enable on-site production of radiotracers - the radioactive compounds essential for PET imaging and theranostic applications - - for diagnosis of serious conditions including cancer and heart disease.

Revolution Vibe delivers one-beat full-heart imaging, 50% faster exams, doubled CCTA capacity, with first installation in France.

Vivid Pioneer offers 360% faster AI, FDA clearance, CE Mark approval, advanced 2D/4D imaging, automated diagnostics, and streamlined clinician workflow.

Definium Pace Select ET, a new floor-mounted digital X-ray system enables access to affordable, high-quality medical imaging technology.

New data highlights GE HealthCare’s job creation, innovation, and manufacturing leadership across Wisconsin, South Carolina, Ohio, and Utah.

FDA updates Vizamyl label to improve Alzheimer’s diagnosis, therapy monitoring, and dementia risk prediction, enabling more precise, timely patient care.

GE HealthCare’s PET/CT, SPECT/CT, and Flyrcado enhance cardiac diagnostics with advanced molecular imaging, offering deeper biological insights than traditional methods.

The company debuts AI-powered LesionID Pro and imaging systems to streamline theranostics, enabling faster, personalized cancer diagnosis and treatment monitoring.